Changes to the website
Sponsored By
Cleveland Clinic Brain Tumor and Neuro-Oncology Center
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 26 to 50 of about 4879

Previous 25           Next 25
Website Changes
09/08/2016 Human cytomegalovirus encoded chemokine receptor US28 activates the HIF-1a/PKM2 axis in glioblastoma cells.
09/07/2016 DelMar Pharmaceuticals and Accurexa to Collaborate in the Development of a Novel Combination Chemotherapy for the Local Treatment of Brain Cancer
09/07/2016 NY Islanders fundraiser for Brain Tumor Research!
09/07/2016 The fourth weapon in the battle against cancer
09/01/2016 Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review.
09/01/2016 Biological effect of an alternating electric field on cell proliferation and synergistic antimitotic effect in combination with ionizing radiation.
09/01/2016 Tumor treating fields inhibit glioblastoma cell migration, invasion and angiogenesis.
08/31/2016 Musella Foundation Copay Assistance Program reopens!
08/31/2016 Immunotherapy, Vaccines Offer Promise in Glioblastoma, But Data is Still Preliminary
08/31/2016 Kadmon launches mid-stage study of lead oncology candidate in brain cancer
08/25/2016 NY Islanders fundraiser for Brain Tumor Research!
08/24/2016 Update published for "Treatment Options For Glioblastoma and other Glioma"
08/23/2016 Curcumin Changes the Polarity of Tumor-Associated Microglia and Eliminates Glioblastoma.
08/18/2016 Tamoxifen Induces Cytotoxic Autophagy in Glioblastoma.
08/18/2016 Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma.
08/18/2016 Clinical utility and treatment outcome of comprehensive genomic profiling in high grade glioma patients.
08/16/2016 Novocure Converts More Than 500 U.S. Patients to Second Generation Optune within Four Weeks of FDA Approval on July 13
08/10/2016 Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapy.
08/10/2016 Call for chefs to enter Flo’s Chili Cook-Off
07/26/2016 NCCN Guidelines Recommend Optune as a Standard Treatment Option for Newly Diagnosed Glioblastoma
07/26/2016 International Study Finds Effective, Less Toxic Way to Treat Brain Tumors
07/26/2016 International Study Finds Effective, Less Toxic Way to Treat Brain Tumors
07/26/2016 Musella Foundation awards $149,992 in 3 brain tumor research grants.
07/26/2016 Musella Foundation Co-payment Assistance Program is now closed to new patients

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2016 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557

Website Design By
World Wide Websites